arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

LENSAR, Inc.

LNSR
$6.08 ▲ +0.32 (+5.56%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
30 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
50
Health
Fair
Neutral
auto_awesome

Analytical Summary

LENSAR, Inc. shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $73.9M
Dividend Yield
Revenue Growth -5.2%
Op. Margin 16.7%
ROIC 16.4%
FCF / Share $-0.35
Trailing P/E 3.9x
Price / Book 6.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

30-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.43M
↓ -5.2%
Net Income Profit after all expenses
$36.33M
↑ +2591.9%
Operating Margin Operating profit as % of sales
16.7%
↑ +154.3% 6th
FCF / Share Free cash flow per share
$-0.35
↑ +40.5%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
100
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters